(R)-1-m-Tolylethanamine is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its enantiomeric purity makes it valuable in the production of drugs that require specific stereochemistry to achieve desired therapeutic effects. It is often employed in the development of compounds targeting central nervous system disorders, such as antidepressants and antipsychotics, due to its structural compatibility with neurotransmitter systems. Additionally, it serves as an intermediate in the synthesis of agrochemicals, where its chiral nature can enhance the efficacy and selectivity of pesticides or herbicides. In research, it is used to study chiral catalysis and asymmetric synthesis, contributing to advancements in organic chemistry methodologies.